Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Eur J Cancer Prev. 2023 Jul 1;32(4):391-395. doi: 10.1097/CEJ.0000000000000798. Epub 2023 Mar 27.
The common use of genetic testing has reinvigorated discussions surrounding enhanced cancer surveillance, chemoprevention, and preventive surgery strategies due to increasing recognition of pathogenic germline genetic variants. Prophylactic surgery for hereditary cancer syndromes can significantly reduce the risk of developing cancer. Hereditary diffuse gastric cancer (HDGC), characterized by high penetrance and an autosomal dominant inheritance pattern, is causally linked to germline mutations in the CDH1 tumor suppressor gene. Risk-reducing total gastrectomy is currently recommended in patients with pathogenic and likely pathogenic CDH1 variants; however, the physical and psychosocial sequelae of complete stomach removal are substantial and need to be investigated further. In this review, we address the risks and benefits of prophylactic total gastrectomy for HDGC in the context of prophylactic surgery for other highly penetrant cancer syndromes.
由于越来越多的致病性种系基因突变被认识到,遗传检测的普遍应用重新引发了关于增强癌症监测、化学预防和预防性手术策略的讨论。遗传性癌症综合征的预防性手术可以显著降低患癌症的风险。遗传性弥漫性胃癌(HDGC)的特征是高外显率和常染色体显性遗传模式,与 CDH1 肿瘤抑制基因的种系突变有关。目前建议对致病性和可能致病性 CDH1 变异的患者进行风险降低性全胃切除术;然而,完全胃切除的身体和心理社会后遗症是巨大的,需要进一步研究。在这篇综述中,我们根据其他高外显率癌症综合征的预防性手术情况,讨论了预防性全胃切除术治疗 HDGC 的风险和益处。